Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
Background and Objectives High-dose melphalan and autologous stem cell transplantation is currently the treatment of choice for selected patients with AL amyloidosis; however, new treatments are needed for patients who are ineligible for or relapse after this procedure. Bortezomib is a proteasome in...
Gardado en:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2007-10-01
|
| Series: | Haematologica |
| Acceso en liña: | https://haematologica.org/article/view/4600 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|